Price Band
₹43 - ₹43
Lot Size
3000
Issue Size
₹16.1 Cr
GMP
N/A
Subscription
382.14x
Analyzing...
IPO Schedule
1
Open
8 Aug 2025
2
Close
12 Aug 2025
3
Allotment
-
4
Listing
18 Aug 2025
About Medistep Healthcare
Medistep Healthcare is an SME operating in the healthcare sector. The company's specific area of focus and services offered are not explicitly mentioned but can be inferred to be related to healthcare based on its name.
Key Strengths
- High Return on Equity (ROE) of 29.06% indicates efficient profitability and shareholder value creation.
- Relatively low Price-to-Earnings (P/E) ratio of 10.86 suggests the IPO may be attractively priced compared to industry peers (requires further peer analysis).
- SME listing provides potential for high growth and expansion.
- Fixed price IPO simplifies investment decision-making.
- The healthcare sector is generally considered defensive and may offer stability in volatile markets.
Risk Factors
- •Small issue size (₹16.1 Cr) may lead to limited liquidity in the secondary market.
- •As an SME, the company may be more susceptible to economic downturns and industry-specific challenges.
- •Lack of detailed information on the company's specific business model and competitive landscape makes a comprehensive risk assessment difficult.
Valuation Analysis
The P/E ratio of 10.86 appears reasonable and potentially undervalued, however, a thorough comparative analysis with similar companies in the healthcare sector is crucial to validate this observation. Investors should carefully consider the limited information available before investing.
IPO Details
ExchangeNSE
SegmentSME
ISININE0UOY01019
NSE SymbolMEDISTEP
Face Value₹10
Lot Size3000
Issue Size₹16.1 Cr
Key Metrics
ROE29.06%
ROCE38.91%
P/E Ratio10.86
Industry P/E20
EPS3.96
PAT Margin8.35%
Growth & Quality
ProfitableYes ✓
Subscription
Total9.48x
Imbalance Ratio1.7x
Documents
RHP not available
Key Dates
Open Date8 Aug 2025
Close Date12 Aug 2025
Listing18 Aug 2025